Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic ...
Opinion
Russell N. Myers: Volition: Women are changing the world
The issues are complex, with no single causative factor. Yet central to these changes is the role of volition – human agency. Women everywhere have made and are making their own decisions about ...
Fred Hutchinson Cancer Center4h
Physician assistant cares for colon cancer patients — then she became one
Bekah Kooy, 38, was convinced she had food poisoning when she felt nauseated and experienced stomach pain following lunch one ...
The Times of Northwest Indiana22h
Former assistant chief and county council member Eldon Strong dies: 'His whole life was public service'
"He was a tough guy who took everything very seriously, but he had a great heart and that showed in his public service. He ...
pharmaphorum21h
Teva's long-acting schizophrenia drug rejected by FDA
Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.